These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 27538636)
1. Prospective study on the chemokine CXCL13 in neuroborreliosis and other aseptic neuroinfections. Pícha D; Moravcová L; Smíšková D J Neurol Sci; 2016 Sep; 368():214-20. PubMed ID: 27538636 [TBL] [Abstract][Full Text] [Related]
2. [Diagnostic relevance of the chemokine CXCL13 and anti-C6 peptide antibodies in patients with neuroborreliosis]. Pícha D; Moravcová L; Smíšková D Epidemiol Mikrobiol Imunol; 2017; 66(2):80-85. PubMed ID: 28691831 [TBL] [Abstract][Full Text] [Related]
3. CXCL13 concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other neurological disorders determined by Luminex and ELISA. Markowicz M; Schötta AM; Kundi M; Bogovič P; Ogrinc K; Strle F; Stanek G Ticks Tick Borne Dis; 2018 Jul; 9(5):1137-1142. PubMed ID: 29705691 [TBL] [Abstract][Full Text] [Related]
4. Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6. Leth TA; Dessau RB; Møller JK Ticks Tick Borne Dis; 2022 Sep; 13(5):101984. PubMed ID: 35709639 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children. Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964 [TBL] [Abstract][Full Text] [Related]
6. CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation. Hytönen J; Kortela E; Waris M; Puustinen J; Salo J; Oksi J J Neuroinflammation; 2014 Jun; 11():103. PubMed ID: 24920219 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis. Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242 [TBL] [Abstract][Full Text] [Related]
8. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis. Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887 [TBL] [Abstract][Full Text] [Related]
9. [CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine]. Rupprecht TA; Lechner C; Tumani H; Fingerle V Nervenarzt; 2014 Apr; 85(4):459-64. PubMed ID: 24682168 [TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study. Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668 [TBL] [Abstract][Full Text] [Related]
11. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables. Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360 [No Abstract] [Full Text] [Related]
12. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. Bremell D; Mattsson N; Edsbagge M; Blennow K; Andreasson U; Wikkelsö C; Zetterberg H; Hagberg L BMC Neurol; 2013 Jan; 13():2. PubMed ID: 23294475 [TBL] [Abstract][Full Text] [Related]
13. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. Ljøstad U; Mygland A J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056 [TBL] [Abstract][Full Text] [Related]
14. Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases. Pilz G; Steger R; Wipfler P; Otto F; Afazel S; Haschke-Becher E; Trinka E; Harrer A J Neuroimmunol; 2020 Jan; 338():577087. PubMed ID: 31715459 [TBL] [Abstract][Full Text] [Related]
15. The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. Rupprecht TA; Plate A; Adam M; Wick M; Kastenbauer S; Schmidt C; Klein M; Pfister HW; Koedel U J Neuroinflammation; 2009 Dec; 6():42. PubMed ID: 20042073 [TBL] [Abstract][Full Text] [Related]
16. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Schmidt C; Plate A; Angele B; Pfister HW; Wick M; Koedel U; Rupprecht TA Neurology; 2011 Mar; 76(12):1051-8. PubMed ID: 21422457 [TBL] [Abstract][Full Text] [Related]
17. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children. Skogman BH; Lager M; Henningsson AJ; Tjernberg I Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535 [TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children. Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid CXCL13 in non-borrelial central nervous system infections: contribution of CXCL13 to the differential diagnosis. Smíšková D; Džupová O; Moravcová L; Pícha D Infect Dis (Lond); 2023 Aug; 55(8):551-558. PubMed ID: 37317698 [TBL] [Abstract][Full Text] [Related]
20. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study. Knudtzen FC; Nilsson AC; Hovius JW; Skarphedinsson S Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1461-1470. PubMed ID: 32172371 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]